BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38126890)

  • 1. The prognostic value of the post-treatment serum CA 125 level in patients with advanced endometrial cancer.
    Muzykiewicz KP; Iwanska E; Pniewska KW; Janeczek M; Nowak-Jastrzab M; Kalamacki A; Karolewski K; Blecharz P
    Ginekol Pol; 2023 Dec; ():. PubMed ID: 38126890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of the prognostic value of the neutrophil/ lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients.
    Muzykiewicz KP; Iwanska E; Janeczek M; Glanowska I; Karolewski K; Blecharz P
    Ginekol Pol; 2021; 92(1):16-23. PubMed ID: 33448001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer.
    Badora-Rybicka A; Nowara E; Starzyczny-Słota D
    ESMO Open; 2016; 1(2):e000039. PubMed ID: 27843595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
    Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
    World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer.
    Pirlog CF; Cotan HT; Parosanu A; Orlov Slavu C; Popa AM; Iaciu C; Olaru M; Oprita AV; Nita I; Nitipir C
    Cureus; 2022 Jul; 14(7):e26843. PubMed ID: 35974841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
    Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
    PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma.
    Cai W; Zhang J; Chen Y; Kong W; Huang Y; Huang J; Zhou L
    Chin J Cancer; 2017 May; 36(1):47. PubMed ID: 28521783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of preoperative serum CA 125 levels in patients with endometrial carcinoma.
    Nikolaou M; Kourea HP; Tzelepi V; Adonakis G; Scopa CD; Tsapanos V; Kardamakis D; Kalofonos C; Decavalas G
    J BUON; 2014; 19(1):198-202. PubMed ID: 24659664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.
    Wohlmuth C; Djedovic V; Kjaer SK; Jensen A; Glasspool R; Roxburgh P; DeFazio A; Johnatty SE; Webb PM; Modugno F; Lambrechts D; Schildkraut JM; Berchuck A; Thomsen LCV; Bjorge L; Høgdall E; Høgdall CK; Goode EL; Winham SJ; Matsuo K; Karlan BY; Lester J; Goodman MT; Thompson PJ; Pejovic T; Riggan MJ; Lajkosz K; Tone A; May T
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.
    Seidel C; Busch J; Weikert S; Steffens S; Fenner M; Ganser A; Grünwald V
    Eur J Cancer; 2012 May; 48(7):1023-30. PubMed ID: 22436979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer.
    Xu X; Wang Y; Wang F; Jia L; Zhou Y; Deng F; Qu J; Zhou B; Meng A; Fu B; Chen X; Qian Z; Wang J
    J Ovarian Res; 2013; 6():31. PubMed ID: 23618037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.
    Chen X; Zhang J; Cheng W; Chang DY; Huang J; Wang X; Jia L; Rosen DG; Zhang W; Yang D; Gershenson DM; Sood AK; Bast RC; Liu J
    Int J Gynecol Cancer; 2013 Jun; 23(5):815-22. PubMed ID: 23669443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors.
    Lyu J; Yang N; Xiao L; Nie X; Xiong J; Liu Y; Zhang M; Zhang H; Tang C; Pan S; Liang L; Bai H; Li C; Kuang H; Li T
    Front Nutr; 2023; 10():1113875. PubMed ID: 36969820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.
    Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X
    J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer.
    Merlo S; Besic N; Drmota E; Kovacevic N
    Radiol Oncol; 2021 Aug; 55(3):341-346. PubMed ID: 33675192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.